IP Verse

Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or Remodeling

Patent No. EP2887961 (titled "Nep Inhibitors For Treating Diseases Characterized By Atrial Enlargement Or Remodeling") was filed by Novartis on Aug 22, 2013. The application was issued on Apr 28, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ALGEMEEN OCTROOI EN MERKENBUREAUJan 28, 2022ALGEMEEN OCTROOI EN MERKENBUREAU
GENERICS UKJan 28, 2022ELKINGTON AND FIFE
STADA ARZNEIMITTELJan 28, 2022KERNEBECK
TEVA PHARMACEUTICALSJan 27, 2022D YOUNG
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBJan 27, 2022SONNENHAUSER
ALFRED E TIEFENBACHERJan 26, 2022HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2887961

NOVARTIS
Application Number
EP13750725A
Filing Date
Aug 22, 2013
Status
Revoked
Dec 9, 2022
Publication Date
Apr 28, 2021
External Links
Slate, Register , Google Patents